Myomo Inc. with ticker code (MYO) have now 5 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 36.5 and 14.5 with the average target price sitting at 22.2. Given that the stocks previous close was at 10.52 this indicates there is a potential upside of 111.0%. There is a 50 day moving average of 11.53 and the 200 day MA is 10.29. The market capitalisation for the company is $61m. You can visit the company’s website by visiting: http://www.myomo.com
Myomo, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo was incorporated in 2004 and is headquartered in Boston, Massachusetts.